Patellofemoral Pain Syndrome
Conditions
Brief summary
The purpose of this study is to determine the efficacy of blood restriction therapy by comparing increase in muscle mass and strength in patients that receive blood restriction therapy to patients who receive a placebo.
Interventions
PROCEDUREPlacebo
Patients will be receiving blood flow restriction therapy with a pressure cuff set to a placebo pressure setting.
PROCEDUREPersonalized Tourniquet System for Blood Flow Restriction
Patients will be receiving blood flow restriction therapy with a pressure cuff
Sponsors
NYU Langone Health
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Caregiver)
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* ASA class I-II * Diagnosed with patellofemoral pain syndrome
Exclusion criteria
* Patients with confirmed radiographic evidence explaining knee pain * Legally incompetent or mentally impaired (e.g. minors, Alzheimer's subjects, dementia, etc.) * Younger than 18 years of age or older than 65 * Any patient considered a vulnerable subject * Patients with impaired circulation, peripheral vascular compromise, Previous revascularization of the extremity, or severe hypertension * Patients with Sickle cell anemia or venous thromboembolism * Patients with Sickle cell anemia or venous thromboembolism * Patients with cancer or Lymphectomies * Patients with increased intracranial pressure
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Increase in Muscle Mass Measured by Biodex | 6 Weeks | Biodex dynamometer is used under standard of care to measure the extensor strength of both legs and have bilateral thigh circumference measured |
| Decrease in Pain measured by Visual Analog Scale (VAS) | 6 Weeks | 100-mm horizontal line anchored at one end with the words no pain and at the other end with the words worst pain imaginable. |
Countries
United States
Outcome results
None listed